Apricot-P: A randomized placebo-controlled phase II study of COX-2 inhibitor apricoxib or placebo in combination with gemcitabine and erlotinib in advanced or metastatic adenocarcinoma of the pancreas ...
Locally advanced pancreatic cancer (LAPC) - a tumor that, while still confined to the pancreas, involves major abdominal blood vessels—is one of the worst forms of an already deadly tumor, as it ...
Up-titration of sorafenib for hepatocellular carcinoma: Impact on duration of exposure and cost. This is an ASCO Meeting Abstract from the 2017 Gastrointestinal Cancers Symposium. This abstract does ...
Research article published in Pancreas Journal reports initial safety and clinical outcome data from a Phase 2a clinical trial of IT LSAM-PTX in LAPC. Two posters presented at AACR Special Conference ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results